Search research articles
Contact Us
Filters
Showing results (241-250 of 251) with videos related to
Page
of 26
Sort By:
Blood Advances
|
July 15, 2021
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity
Uri Greenbaum, Paolo Strati, Rima M Saliba, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 18, 2024
Detection of Bronchiolitis Obliterans Syndrome after Pediatric Hematopoietic Stem Cell Transplantation: An Official American Thoracic Society Clinical Practice Guideline
Shivanthan Shanthikumar, William A Gower, Saumini Srinivasan, et al.
Blood Cancer Discovery
|
June 10, 2022
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression
Guangchun Han, Qing Deng, Mario L Marques-Piubelli, et al.
The Lancet. Oncology
|
January 25, 2022
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial
Michael L Wang, Preetesh Jain, Shuangtao Zhao, et al.
Blood Advances
|
March 20, 2020
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL
Preetesh Jain, Shaojun Zhang, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology
|
April 3, 2020
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients
Shuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 6, 2021
Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship
L Jeffrey Medeiros, Mario L Marques-Piubelli, Valentina F I Sangiorgio, et al.
Blood Cancer Discovery
|
May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma
Neeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
Nature Medicine
|
March 14, 2023
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
Christoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, et al.
Blood
|
October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy
Rishika Prasad, Abdur Rehman, Lubna Rehman, et al.
Page
of 26
Search research articles
Search
Showing results (241-250 of 251) with videos related to
Sort By:
Page
of 26
Blood Advances
|
July 15, 2021
CRP and ferritin in addition to the EASIX score predict CAR-T-related toxicity
Uri Greenbaum, Paolo Strati, Rima M Saliba, et al.
American Journal of Respiratory and Critical Care Medicine
|
June 18, 2024
Detection of Bronchiolitis Obliterans Syndrome after Pediatric Hematopoietic Stem Cell Transplantation: An Official American Thoracic Society Clinical Practice Guideline
Shivanthan Shanthikumar, William A Gower, Saumini Srinivasan, et al.
Blood Cancer Discovery
|
June 10, 2022
Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression
Guangchun Han, Qing Deng, Mario L Marques-Piubelli, et al.
The Lancet. Oncology
|
January 25, 2022
Ibrutinib-rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial
Michael L Wang, Preetesh Jain, Shuangtao Zhao, et al.
Blood Advances
|
March 20, 2020
Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL
Preetesh Jain, Shaojun Zhang, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology
|
April 3, 2020
Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients
Shuangtao Zhao, Rashmi Kanagal-Shamanna, Lucy Navsaria, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 6, 2021
Epstein-Barr-virus-positive large B-cell lymphoma associated with breast implants: an analysis of eight patients suggesting a possible pathogenetic relationship
L Jeffrey Medeiros, Mario L Marques-Piubelli, Valentina F I Sangiorgio, et al.
Blood Cancer Discovery
|
May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma
Neeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
Nature Medicine
|
March 14, 2023
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
Christoph K Stein-Thoeringer, Neeraj Y Saini, Eli Zamir, et al.
Blood
|
October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy
Rishika Prasad, Abdur Rehman, Lubna Rehman, et al.
Page
of 26